BSE_DLY:3BBLACKBIO   3B BLACKBIO DX LIMITED
Currently Market Price @ 786.55 ... Good for Holding for a Year .

Company has reduced debt.
Company is almost debt free.
Company has delivered good profit growth of 49.9% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 44.5%
Promoter holding has increased by 2.86% over last quarter.


Launch of Subsidiary Co.
3B BlackBio has launched its own subsidiary co. in the United Kingdom after entering into a Joint Venture Agreement with its European Distributor, HS Biolabs Limited based in Manchester, UK. TRUPCR Europe Limited has been launched to accelerate growth of TRUPCR's range of molecular diagnostic kits within Europe. TRUPCR has been well-accepted in 35+ countries across UK and Europe, Middle East, APAC, LATAM and United States of America


3B BlackBio Biotech India Limited.

Incorporated in 2011, “3B BlackBio Biotech India Limited”, a subsidiary of Kilpest India Limited, is engaged in Design, Development Manufacturing and Commercialization of qPCR tests, Rapid tests, NGS based Molecular Diagnostic Kits and Extraction Kits. The company has the largest range of CE-IVD products in the molecular diagnostics segment.
Brands: TRUPCR, TRURAPID, truNGS, TRUPCR Europe.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.